SAGE-217 Capsules as Adjunctive Treatment in Tremor Predominant Parkinson's Disease in an Open-label, Phase 2 Pilot Clinical Trial

Bullock, A; Kaul, I; Li, SG; Silber, C; Kanes, S

MOVEMENT DISORDERS, 2018; 33 (): S68